Logopedie bij de ziekte van Parkinson - Logopedie.nl

158
Logopedie bij de ziekte van Parkinson
(152) Ramig LO, Dromey C. Aerodynamic mechanisms underlying treatment-related
changes in vocal intensity in patients with Parkinson disease. J Speech Hear Res 1996
Aug;39(4):798-807.
(153) Dejonckere PH, Bradley P, Clemente P, Cornut G, Crevier-Buchman L, Friedrich G, et
al. A basic protocol for functional assessment of voice pathology, especially for investigating
the efficacy of (phonosurgical) treatments and evaluating new assessment
techniques. Guideline elaborated by the Committee on Phoniatrics of the European
Laryngological Society (ELS). Eur Arch Otorhinolaryngol 2001 Feb;258(2):77-82.
(154) Hirano M. Clinical examination of voice. New York: Springer; 1981.
(155) Ramig LO, Fox C, Sapir S. Parkinson’s disease: speech and voice disorders and their
treatment with the Lee Silverman Voice Treatment. Seminars in Speech and Language
2004;25(2):169-80.
(156) Ramig LO, Countryman S, O’Brien C, Hoehn M, Thompson L. Intensive speech treatment
for patients with Parkinson’s disease: short- and long-term comparison of two
techniques. Neurology 1996 Dec;47(6):1496-504.
(157) Swart B de. De ‘Pitch Limiting Voice Treatment’. Keypoint 2004;1:11-3.
(158) Smith ME, Ramig LO, Dromey C, Perez KS, Samandari R. Intensive voice treatment in
Parkinson disease: laryngostroboscopic findings. J Voice 1995 Dec;9(4):453-9.
(159) Ramig LO, Sapir S, Countryman S, Pawlas AA, O’Brien C, Hoehn M, et al. Intensive
voice treatment (LSVT) for patients with Parkinson’s disease: a 2 year follow up.
J Neurol Neurosurg Psychiatry 2001 Oct;71(4):493-8.
(160) Ramig LO, Sapir S, Fox C, Countryman S. Changes in vocal loudness following
intensive voice treatment (LSVT) in individuals with Parkinson’s disease: a comparison
with untreated patients and normal age-matched controls. Mov Disord 2001
Jan;16(1):79-83.
(161) Swart BJ de, Willemse SC, Maassen BA, Horstink MW. Improvement of voicing
in patients with Parkinson’s disease by speech therapy. Neurology 2003 Feb
11;60(3):498-500.
(162) Rascol O, Goetz C, Koller W, Poewe W, Sampaio C. Treatment interventions for Parkinson’s
disease: an evidence based assessment. Lancet 2002 May 4;359(9317):1589-
98.
(163) Ramig LO, Countryman S, O’Brien C, Hoehn M, Thompson L. Intensive speech treatment
for patients with Parkinson’s disease: short-and long-term comparison of two
techniques. Neurology 1996 Dec;47(6):1496-504.
(164) Pinto S, Ozsancak C, Tripoliti E, Thobois S, Limousin-Dowsey P, Auzou P. Treatments
for dysarthria in Parkinson’s disease. Lancet Neurol 2004 Sep;3(9):547-56.
(165) Spielman JL, Borod JC, Ramig LO. The effects of intensive voice treatment on facial
expressiveness in Parkinson disease: preliminary data. Cogn Behav Neurol 2003
Sep;16(3):177-88.
(166) Elman RJ, Bernstein-Ellis E. The efficacy of group communication treatment in adults
with chronic aphasia. J Speech Lang Hear Res 1999 Apr;42(2):411-9.